Michael P. Federle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michael P. Federle has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
A. Blachar
Division of Abdominal Imaging, Department of Radiology, University of Pittsburgh Medical Center, 200 Lothrop Street, Pittsburgh, PA 15213, USA
1 shared publicationAlessandro Furlan
Department of Radiology, University of Pittsburgh Medical Center, Presbyterian Campus, 200 Lothrop St., Pittsburgh, PA, USA
1 shared publicationArtemis Gogos
1 shared publicationDuo-Sheng Wang
1 shared publication- Giuseppe Brancatelli
Department of Radiology, University of Palermo, Palermo, Sicily, Italy
1 shared publication Jennifer T. Ames
University of Pittsburgh Medical Center
1 shared publication
Latest Publications
- Open Access
- 1 January 2018
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (3) , 931-940
A novel chemical inducer of Streptococcus quorum sensing acts by inhibiting the pheromone-degrading endopeptidase PepO
- 1 January 2018
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (3) , 931-940
Open AccessA novel chemical inducer of Streptococcus quorum sensing acts by inhibiting the pheromone-degrading endopeptidase PepO
- 9 August 2016
- Published by Springer Nature in Abdominal Radiology
- Vol. 42 (1) , 90-100
Contrast media for fluoroscopic examinations of the GI and GU tracts: current challenges and recommendations
One of the significant challenges facing radiologists who perform and interpret studies of the gastrointestinal and genitourinary systems have been periodic interruptions in the availability of barium and iodinated contrast media specially formulated for gastrointestinal (GI) and genitourinary (GU) studies. These interruptions are due to the US Food and Drug Administration’s recent requirement for more stringent documentation of the safety and efficacy of contrast media and the consolidation among contrast manufacturers. Therefore, radiologists may be required to recommend an alternative means of evaluation, such as computed tomography, magnetic resonance, or endoscopy, or they may need to substitute a different formulation of a contrast agent not specifically developed for GI or GU use, for example the utilization of an agent designed and marketed for vascular use. This article reviews the current status of fluoroscopic contrast media, and provides suggestions and recommendations for the optimal and alternative use of contrast media formulations.
- 9 August 2016
- Published by Springer Nature in Abdominal Radiology
- Vol. 42 (1) , 90-100
Contrast media for fluoroscopic examinations of the GI and GU tracts: current challenges and recommendations
One of the significant challenges facing radiologists who perform and interpret studies of the gastrointestinal and genitourinary systems have been periodic interruptions in the availability of barium and iodinated contrast media specially formulated for gastrointestinal (GI) and genitourinary (GU) studies. These interruptions are due to the US Food and Drug Administration’s recent requirement for more stringent documentation of the safety and efficacy of contrast media and the consolidation among contrast manufacturers. Therefore, radiologists may be required to recommend an alternative means of evaluation, such as computed tomography, magnetic resonance, or endoscopy, or they may need to substitute a different formulation of a contrast agent not specifically developed for GI or GU use, for example the utilization of an agent designed and marketed for vascular use. This article reviews the current status of fluoroscopic contrast media, and provides suggestions and recommendations for the optimal and alternative use of contrast media formulations.
- 8 January 2011
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 56 (7) , 2179-2184
Septic Thrombophlebitis of the Portal Venous System: Clinical and Imaging Findings in Thirty-Three Patients
Our purpose was to review the clinical and imaging findings in a series of patients with septic thrombophlebitis of the portal venous system in order to define criteria that might allow more confident and timely diagnosis. This is a retrospective case series. The clinical and imaging features were analyzed in 33 subjects with septic thrombophlebitis of the portal venous system. All 33 patients with septic thrombophlebitis of the portal venous system had pre-disposing infectious or inflammatory processes. Contrast-enhanced CT studies of patients with septic thrombophlebitis typically demonstrate an infectious gastrointestinal source (82%), thrombosis (70%), and/or gas (21%) of the portal system or its branches, and intrahepatic abnormalities such as a transient hepatic attenuation difference (THAD) (42%) or abscess (61%). Septic thrombophlebitis of the portal system is often associated with an infectious source in the gastrointestinal tract and sepsis. Contrast-enhanced CT demonstrates an infectious gastrointestinal source, thrombosis or gas within the portal system or its branches, and intrahepatic abnormalities such as abscess in most cases. We report a THAD in several of our patients, an observation that was not made in prior reports of septic thrombophlebitis.
- 8 January 2011
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 56 (7) , 2179-2184
Septic Thrombophlebitis of the Portal Venous System: Clinical and Imaging Findings in Thirty-Three Patients
Our purpose was to review the clinical and imaging findings in a series of patients with septic thrombophlebitis of the portal venous system in order to define criteria that might allow more confident and timely diagnosis. This is a retrospective case series. The clinical and imaging features were analyzed in 33 subjects with septic thrombophlebitis of the portal venous system. All 33 patients with septic thrombophlebitis of the portal venous system had pre-disposing infectious or inflammatory processes. Contrast-enhanced CT studies of patients with septic thrombophlebitis typically demonstrate an infectious gastrointestinal source (82%), thrombosis (70%), and/or gas (21%) of the portal system or its branches, and intrahepatic abnormalities such as a transient hepatic attenuation difference (THAD) (42%) or abscess (61%). Septic thrombophlebitis of the portal system is often associated with an infectious source in the gastrointestinal tract and sepsis. Contrast-enhanced CT demonstrates an infectious gastrointestinal source, thrombosis or gas within the portal system or its branches, and intrahepatic abnormalities such as abscess in most cases. We report a THAD in several of our patients, an observation that was not made in prior reports of septic thrombophlebitis.
- 1 October 2009
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 193 (4) , 1077-1087
Spontaneous Abdominal Hemorrhage: Causes, CT Findings, and Clinical Implications
OBJECTIVE. The purpose of this article is to present the most common causes of spontaneous abdominal hemorrhage and to review the CT findings that are important in establishing the correct diagnosis and in guiding appropriate therapy.CONCLUSION. Knowledge of the common CT manifestations of various causes of spontaneous abdominal hemorrhage allows their accurate diagnosis and has a direct impact on clinical decision making.
- 1 October 2009
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 193 (4) , 1077-1087
Spontaneous Abdominal Hemorrhage: Causes, CT Findings, and Clinical Implications
OBJECTIVE. The purpose of this article is to present the most common causes of spontaneous abdominal hemorrhage and to review the CT findings that are important in establishing the correct diagnosis and in guiding appropriate therapy.CONCLUSION. Knowledge of the common CT manifestations of various causes of spontaneous abdominal hemorrhage allows their accurate diagnosis and has a direct impact on clinical decision making.
- 1 March 2002
- Published by Springer Nature in Abdominal Radiology
- Vol. 27 (2) , 188-190
Acute fulminant hepatic infection causing fatal “emphysematous hepatitis”: case report
We describe a case of fatal fulminant hepatic infection with gas replacement of the hepatic parenchyma and no evidence of a liquified abscess in a diabetic patient: a case of “emphysematous hepatitis,” the hepatic equivalent of emphysematous pyelonephritis. Computed tomography and clinical findings are described.
- 1 March 2002
- Published by Springer Nature in Abdominal Radiology
- Vol. 27 (2) , 188-190
Acute fulminant hepatic infection causing fatal “emphysematous hepatitis”: case report
We describe a case of fatal fulminant hepatic infection with gas replacement of the hepatic parenchyma and no evidence of a liquified abscess in a diabetic patient: a case of “emphysematous hepatitis,” the hepatic equivalent of emphysematous pyelonephritis. Computed tomography and clinical findings are described.